Endometrial cancer is the most common gynecologic malignancy. It is the fourth most common cancer in women after breast, lung, and colorectal cancers. Endometrial cancer is generally classified into two types. Type I is the most common form, representing more than 70% of cases. Type I tumors are associated with unopposed estrogen stimulation and are known as endometrioid adenocarcinoma. https://www.creativebiolabs.net/endometrial-cancer-overview-signaling-pathway-diagnosis-targeted-therapy.htm
Drug DiscoveryImmunology